Merck To Pay $3.85B For Hepatitis C Drug Developer

Now watching

Next video starts in : 7 Play

Merck To Pay $3.85B For Hepatitis C Drug Developer

Merck To Pay $3.85B For Hepatitis C Drug Developer
Replay video
Up next

These People are REALLY Ready for Warren

Unlock your personal NFL Now stream by signing in to NFL.com

Merck To Pay $3.85B For Hepatitis C Drug Developer

by Wochit 0:45 mins

Merck To Pay $3.85B For Hepatitis C Drug Developer

by Wochit 0:45 mins

Pharmaceutical giant Merck will spend about $3.85 billion for Idenix Pharmaceuticals Inc., a small company developing hepatitis C medicines that, together with Merck's experimental drugs, could produce lucrative combo therapies that quickly cure most patients with the blood-borne virus afflicting tens of millions. The price for the deal announced Monday — a per-share bid more than triple Friday's closing price for Cambridge, Massachusetts-based Idenix — seems high. However, the latest hepatitis C medicines command very high prices, the number of patients keeps rising and Merck was bidding against rivals.

Wochit

Must Watch

  1. 22:03

    Sin City Saints Episode 1: The Fool Monty

  2. 23:15

    Sin City Saints Episode 2: Smoke and Mirrors

  3. 24:40

    Community Episode 3: Basic Crisis Room Decorum

  4. 1:22

    Meet the star point guard of the Sin City Saints

  5. 2:52

    A 900 Calorie Cocktail? What's in Your Drink?

  6. 0:31

    Roast of Justin Bieber - Shaquille O'Neal - Straighten Up

Community

  1. 27:26

    Community Episode 1: Ladders

  2. 27:26

    Community Episode 2: Lawnmower Maintenance and Postnatal Care

  3. 24:40

    Community Episode 3: Basic Crisis Room Decorum

  4. 0:29

    Watch a Sneak Peek of Community Episode 4

  5. 2:01

    Sin City Saints: Official Trailer